Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06390111
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2024-04-19
Brief Title:
A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS High-grade TaT1 and no Complete Response to First Nadofaragene Firadenovec Dose
Sponsor:
Ferring Pharmaceuticals
Organization:
Ferring Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-17
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-19
First Submit QC Date:
April 25 2024
Study First Post Date:
2024-04-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-21
Last Update Post Date:
2024-06-28
Last Update Post Date Type:
ACTUAL